Vertex Pharmaceuticals Incorporated (VRTX) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer
Vertex Pharmaceuticals Incorporated (VRTX) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (86% profit margin, 20% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
VRTX Smart-Money Thermometer: BALANCED INSTITUTIONAL POSITIONING
Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (VRTX)
No recent open-market Form 4 cluster sales or emergency dumps flagged on VRTX. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live VRTX Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
VRTX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +8.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on VRTX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for VRTX. Explore sector supply chains on /butterfly.
VRTX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDAre VRTX insiders and hedge funds buying or selling?
Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies VRTX leadership and institutional positioning as: BALANCED INSTITUTIONAL POSITIONING.